735 related articles for article (PubMed ID: 25762732)
21. Evaluation of dengue antiviral candidates in vivo in mouse model.
Watanabe S; Vasudevan SG
Methods Mol Biol; 2014; 1138():391-400. PubMed ID: 24696350
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Direct-Acting Antiviral Agent Targeting RNA Helicase via a Graphene Oxide Nanobiosensor.
Kim J; Park SJ; Park J; Shin H; Jang YS; Woo JS; Min DH
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25715-25726. PubMed ID: 34036784
[TBL] [Abstract][Full Text] [Related]
23. Targeting heat shock factor 1 as an antiviral strategy against dengue virus replication in vitro and in vivo.
Tsai TT; Chen CL; Tsai CC; Lin CF
Antiviral Res; 2017 Sep; 145():44-53. PubMed ID: 28733114
[TBL] [Abstract][Full Text] [Related]
24. Repurposing of prochlorperazine for use against dengue virus infection.
Simanjuntak Y; Liang JJ; Lee YL; Lin YL
J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694
[TBL] [Abstract][Full Text] [Related]
25. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
[TBL] [Abstract][Full Text] [Related]
26. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
[TBL] [Abstract][Full Text] [Related]
27. Targeting dengue virus NS4B protein for drug discovery.
Xie X; Zou J; Wang QY; Shi PY
Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection.
Chuang FK; Huang SM; Liao CL; Lee AR; Lien SP; Chiu YL; Chang TH; Tsai PL; Lin RJ; Shih CC; Tsai YJ; Lin GJ; Yen LC
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636070
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo efficacy of Metformin against dengue.
Cheang YZN; Ting HRD; Koh HQV; Alonso S
Antiviral Res; 2021 Nov; 195():105186. PubMed ID: 34655660
[TBL] [Abstract][Full Text] [Related]
30. A Targeted Computational Screen of the SWEETLEAD Database Reveals FDA-Approved Compounds with Anti-Dengue Viral Activity.
Moshiri J; Constant DA; Liu B; Mateo R; Kearnes S; Novick P; Prasad R; Nagamine C; Pande V; Kirkegaard K
mBio; 2020 Nov; 11(6):. PubMed ID: 33173007
[TBL] [Abstract][Full Text] [Related]
31. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78.
Chen HH; Chen CC; Lin YS; Chang PC; Lu ZY; Lin CF; Chen CL; Chang CP
Antiviral Res; 2017 Jun; 142():158-168. PubMed ID: 28238876
[TBL] [Abstract][Full Text] [Related]
32. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
33. Dengue drug discovery: Progress, challenges and outlook.
Lim SP
Antiviral Res; 2019 Mar; 163():156-178. PubMed ID: 30597183
[TBL] [Abstract][Full Text] [Related]
34. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.
Frias-Staheli N; Dorner M; Marukian S; Billerbeck E; Labitt RN; Rice CM; Ploss A
J Virol; 2014 Feb; 88(4):2205-18. PubMed ID: 24335303
[TBL] [Abstract][Full Text] [Related]
35. Brivanib alaninate inhibited dengue virus proliferation through VEGFR2/AMPK pathway.
Wan Y; Wu W; Wan Y; Li L; Zhang J; Chen X; Liu S; Yao X
Pharmacol Res; 2021 Aug; 170():105721. PubMed ID: 34116207
[TBL] [Abstract][Full Text] [Related]
36. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
[TBL] [Abstract][Full Text] [Related]
37. Determinants in Nonstructural Protein 4A of Dengue Virus Required for RNA Replication and Replication Organelle Biogenesis.
Cortese M; Mulder K; Chatel-Chaix L; Scaturro P; Cerikan B; Plaszczyca A; Haselmann U; Bartenschlager M; Neufeldt CJ; Bartenschlager R
J Virol; 2021 Oct; 95(21):e0131021. PubMed ID: 34379504
[TBL] [Abstract][Full Text] [Related]
38. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA
Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930
[TBL] [Abstract][Full Text] [Related]
39. A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection.
Fraser JE; Watanabe S; Wang C; Chan WK; Maher B; Lopez-Denman A; Hick C; Wagstaff KM; Mackenzie JM; Sexton PM; Vasudevan SG; Jans DA
J Infect Dis; 2014 Dec; 210(11):1780-91. PubMed ID: 24903662
[TBL] [Abstract][Full Text] [Related]
40. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.
Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA
Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
